Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Ä¡°ú ȯÀÚ¿¡¼­ÀÇ Perfusor¢ç fm ÀÚ°¡ÅëÁõÁ¶Àý±â¸¦ ÀÌ¿ëÇÑ Propofol ÀÚ°¡ÁøÁ¤Á¶Àý¹ý

Propofol Patient-Controlled Sedation Using Perfusor¢ç fm (B. Braun, Germany) Infusion Pump in Dental Patients-Preliminary Study

´ëÇÑÄ¡°ú¸¶Ãë°úÇÐȸÁö 2002³â 2±Ç 2È£ p.97 ~ 100
¹ÚâÁÖ, ±èÇöÁ¤, ¿°±¤¿ø,
¼Ò¼Ó »ó¼¼Á¤º¸
¹ÚâÁÖ ( Park Chang-Joo ) - ¼­¿ï´ëÇб³ Ä¡°ú´ëÇÐ Ä¡°ú¸¶Ãë°úÇб³½Ç
±èÇöÁ¤ ( Kim Hyun-Jeong ) - ¼­¿ï´ëÇб³ Ä¡°ú´ëÇÐ Ä¡°ú¸¶Ãë°úÇб³½Ç
¿°±¤¿ø ( Yeom Kwang-Won ) - ¼­¿ï´ëÇб³ Ä¡°ú´ëÇÐ Ä¡°ú¸¶Ãë°úÇб³½Ç

Abstract


Background: Patient-controlled sedation (PCS) has been known for a safe and effective sedative method on the same pharmacological concepts of patient-controlled analgesia. Many different kinds of infusion devices have been used but they often have too long nominal infusion rate and lockout time. Perfusor¢ç fm (B. Braun, Germany) is a new PCA device with 999.9 ml/hr nominal infusion rate and minimum 1 min lockout time. In this study, the feasibility of propofol PCS using Perfusor¢ç fm was examined in order to provide a safe satisfactory sedation for dental patients.

Methods: Eleven healthy patients presenting for oral surgery were studied. Propofol PCS was performed using Perfusor¢ç fm, which was set to deliver a bolus dose of 5 mg with 999.9 ml/hr nominal infusion rate and 1 min lockout time. Propofol loading dose was randomly assigned to a bolus dose ¡¿ 0, 2, and 3 (initial bolus). Patients were told to press the bolus button as often as they needed to relieve discomfort.

Results: Total infused-dose of propofol was mean 1.8 mg/kg/hr and D (Delivery)/A (Attempt) ratio was mean 72.8%. All patients was awake and there were no clinically significant intraoperative side effects during the sedation. Almost all patients were very satisfied with this type of PCS.

Conclusion: Propofol PCS using Perfusor¢ç fm infusion pump provided good conscious sedation for dental procedures.

Å°¿öµå

Infusion pumps; Patient-controlled sedation; Propofol

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI